Cargando…

Yes-Associated Protein is Involved in Myocardial Fibrosis in Rats with Diabetic Cardiomyopathy

INTRODUCTION: Recent studies have shown that YAP is closely related to the pathological process of cardiovascular diseases. But the role of YAP in cardiac injury of diabetic cardiomyopathy (DCM) is still unclear. METHODS: Diabetic cardiomyopathy rat model was established and divided into control gro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Maomao, Wang, Han, Li, Shengnan, Yan, Feng, Fu, Changning, Li, Lei, Yu, Yalin, Xiong, Jie, Dong, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128377/ https://www.ncbi.nlm.nih.gov/pubmed/34012279 http://dx.doi.org/10.2147/DMSO.S302466

Ejemplares similares

(Pro)renin receptor involves in myocardial fibrosis and oxidative stress in diabetic cardiomyopathy via the PRR–YAP pathway
por: Yu, Shiran, et al.
Publicado: (2021)

Adropin Alleviates Myocardial Fibrosis in Diabetic Cardiomyopathy Rats: A Preliminary Study
por: Liu, Mao, et al.
Publicado: (2021)

Valvular Cardiomyopathy in Aortic Valve Regurgitation Correlates with Myocardial Fibrosis
por: Petersen, Johannes, et al.
Publicado: (2023)

DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats
por: Zhu, Zhen-Dong, et al.
Publicado: (2019)

The Yes and No of the Ethylene Involvement in Abscission
por: Botton, Alessandro, et al.
Publicado: (2019)

Effects of (Pro)renin Receptor on Diabetic Cardiomyopathy Pathological Processes in Rats via the PRR-AMPK-YAP Pathway
por: Xiong, Jie, et al.
Publicado: (2021)

Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy
por: Cheng, Yanan, et al.
Publicado: (2023)

Irbesartan ameliorates myocardial fibrosis in diabetic cardiomyopathy rats by inhibiting the TGFβ1/Smad2/3 pathway
por: Zong, Min, et al.
Publicado: (2020)

Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy
por: Zhang, Lei, et al.
Publicado: (2016)

Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
por: He, Yi, et al.
Publicado: (2010)

Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
por: Hussain, Tarique, et al.
Publicado: (2013)

Long noncoding RNA ENSRNOG00000037522 is involved in the podocyte epithelial-mesenchymal transition in diabetic rats
por: Ling, Li, et al.
Publicado: (2018)

Single-cell RNA-seq of heart reveals intercellular communication drivers of myocardial fibrosis in diabetic cardiomyopathy
por: Li, Wei, et al.
Publicado: (2023)

Myocardial Protective Effects of Nicorandil on Rats with Type 2 Diabetic Cardiomyopathy
por: Zhang, Meng, et al.
Publicado: (2018)

Erratum to: Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy
por: Zhang, Lei, et al.
Publicado: (2016)

Yes, SiR
por: Fu, Xiang-Dong
Publicado: (2015)

Yes
por: Stanley, Arthur
Publicado: (1923)

Association Between Echocardiographic Non-invasive Myocardial Work Indices and Myocardial Fibrosis in Patients With Dilated Cardiomyopathy
por: Cui, Cunying, et al.
Publicado: (2021)

T(1) mapping for characterization of myocardial fibrosis in hypertrophic cardiomyopathy
por: Liu, Ying, et al.
Publicado: (2016)

Myocardial Fibrosis in Hypertrophic Cardiomyopathy: What Remains to be Proven?
por: Sara, Leonardo
Publicado: (2019)

Follistatin Attenuates Myocardial Fibrosis in Diabetic Cardiomyopathy via the TGF-β–Smad3 Pathway
por: Wang, Yinhui, et al.
Publicado: (2021)

Prohibitin overexpression improves myocardial function in diabetic cardiomyopathy
por: Dong, Wen-qian, et al.
Publicado: (2015)

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
por: Raman, Betty, et al.
Publicado: (2019)

Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts
por: Schlittler, Maja, et al.
Publicado: (2023)

Opinion: Yes
por: Vieira, Marcelo
Publicado: (2015)

Opinion: Yes
por: Althof, Stanley E.
Publicado: (2015)

Opinion: Yes
por: Cintra, Caio Cesar, et al.
Publicado: (2016)

Yes, It Does
por: Cummins, Nathan W.
Publicado: (2021)

Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy
por: Fang, Lu, et al.
Publicado: (2015)

Yes-associated protein inhibition ameliorates liver fibrosis and acute and chronic liver failure by decreasing ferroptosis and necroptosis
por: Zhao, Wen, et al.
Publicado: (2023)

In vivo diffusion-weighted MRI detection of myocardial fibrosis in hypertrophic cardiomyopathy patients
por: Nguyen, Christopher T, et al.
Publicado: (2015)

Hydrogen sulfide alleviates myocardial fibrosis in mice with alcoholic cardiomyopathy by downregulating autophagy
por: Liang, Biao, et al.
Publicado: (2017)

Hypertrophic Cardiomyopathy versus Storage Diseases with Myocardial Involvement
por: Burban, Anna, et al.
Publicado: (2023)

Effect of genistein on myocardial fibrosis in diabetic rats and its mechanism
por: Yang, Rui, et al.
Publicado: (2018)

Mesenchymal stem cells ameliorate myocardial fibrosis in diabetic cardiomyopathy via the secretion of prostaglandin E2
por: Jin, Liyuan, et al.
Publicado: (2020)

Changes in N6-Methyladenosine Modification Modulate Diabetic Cardiomyopathy by Reducing Myocardial Fibrosis and Myocyte Hypertrophy
por: Ju, Wenhao, et al.
Publicado: (2021)

Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy
por: Kuusisto, Johanna, et al.
Publicado: (2012)

Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats
por: Lu, Jing, et al.
Publicado: (2012)

Renal Denervation Findings on Cardiac and Renal Fibrosis in Rats with Isoproterenol Induced Cardiomyopathy
por: Liu, Qian, et al.
Publicado: (2015)

The Protective Effect of Low-Dose Ethanol on Myocardial Fibrosis through Downregulating the JNK Signaling Pathway in Diabetic Rats
por: Yu, Ying, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p7tmdhhet3mruu118tr2oq2pvu